-
ArQule to Participate in Citi’s 13th Annual Biotech Conference on September 6, 2018
-
ArQule Strengthens Executive Team with Two Key Appointments
-
Three Small Cap Biotech Stocks Added to Citi's Most Preferred List (ATRA) (NVAX) (PBYI)
-
Citi Downgrades ArQule (ARQL) to Neutral
-
StreetInsider.com Pre-Open Movers 01/11: (INFY) (DNDN) (BBY) Higher; (ARQL) (KBR) (JCP) Lower (more...)
-
Citi Starts ArQule (ARQL) at Buy
-
Pre-Open Movers 10/02: (CTIC) (INVE) (ILMN) Higher; (ARQL) (EXPR) (CLB) Lower (more...)
-
Notable Analyst Rating Changes 06/15: (NOK) (ORCL) (SAI) Upgraded; (EXC) (PBR) (AUY) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Notable Analyst Rating Changes 7/16: AXP, COP, ORCL, PLCM, JRCC, DIS Upgraded; MOT, ARQL, PM Downgraded
-
Notable Analyst Rating Changes 1/29: ARQL, POT, ESLR, TM Upgraded; MCD, NMX, DIS, PMI Downgraded

